Sporanox and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Sporanox (itraconazole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Flagyl, and have Pseudomonas infection.

The phase IV clinical study analyzes which people have Nosebleed when taking Sporanox. It is created by eHealthMe based on reports of 6,057 people who have side effects when taking Sporanox from the FDA, and is updated regularly.

What is Sporanox?

Sporanox has active ingredients of itraconazole. It is often used in fungal infection. eHealthMe is studying from 6,137 Sporanox users. Check the latest studies of Sporanox.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,074 drugs and 3,094 conditions by eHealthMe. Check the latest studies of Nosebleed.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

6,057 people reported to have side effects when taking Sporanox.
Among them, 43 people (0.71%) have Nosebleed.

Among these 43 people:

How long have people been on Sporanox when they have Nosebleed? *

What is the gender of people who have Nosebleed when taking Sporanox? *

female: 69.05 %
male: 30.95 %

What is the age of people who have Nosebleed when taking Sporanox? *

What are other drugs people take besides Sporanox? *

What are other side effects people have besides Nosebleed? *

Headache (pain in head): 18 people, 41.86%
Thrombocytopenia (decrease of platelets in blood): 13 people, 30.23%
Dyspnea (difficult or laboured breathing): 13 people, 30.23%
Stress And Anxiety: 13 people, 30.23%
Haematoma (collection of blood outside the blood vessels): 12 people, 27.91%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 12 people, 27.91%
Rashes (redness): 11 people, 25.58%
Fatigue (feeling of tiredness): 11 people, 25.58%
Feeling Abnormal: 10 people, 23.26%
Weight Decreased: 10 people, 23.26%

What are the existing conditions these people have? *

Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 9 people, 20.93%
Osteoporosis (bones weak and more likely to break): 3 people, 6.98%
Immunodeficiency: 3 people, 6.98%
High Blood Cholesterol: 2 people, 4.65%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 4.65%
Asthma: 2 people, 4.65%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 4.65%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 4.65%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.65%
Urination - Excessive Volume: 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Sporanox and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sporanox:

Sporanox (6,137 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Sporanox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,074 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,094 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on itraconazole (the active ingredients of Sporanox) and Sporanox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.